Wuppertal, Germany

Klemens Lustig

USPTO Granted Patents = 47 

 

 

Average Co-Inventor Count = 9.0

ph-index = 7

Forward Citations = 187(Granted Patents)


Company Filing History:


Years Active: 1997-2024

Loading Chart...
Loading Chart...
Loading Chart...
47 patents (USPTO):

Title: **Klemens Lustig: Innovator in Respiratory and Cardiovascular Therapeutics**

Introduction

Klemens Lustig, hailing from Wuppertal, Germany, is an accomplished inventor known for his significant contributions to the fields of pharmaceuticals and medicinal chemistry. With a prolific portfolio of 47 patents, Lustig has been at the forefront of developing innovative solutions for treating various health disorders, particularly those related to breathing and cardiovascular conditions.

Latest Patents

Among Lustig's notable recent patents are two groundbreaking inventions. The first, titled "Diazabicyclic Substituted Imidazopyrimidines and Their Use for the Treatment of Breathing Disorders," centers on novel diazabicyclically substituted imidazo[1,2-a]pyrimidine derivatives. This invention focuses on their application for the treatment and prevention of diseases, especially those affecting respiratory health, such as obstructive and central sleep apnea, as well as snoring.

The second recent patent, "Amine Substituted Triazole Derivatives and Uses Thereof," introduces innovative amine substituted 1,2,4-triazole derivatives. This invention encompasses processes for their preparation and highlights their utility in pharmaceutical compositions aimed at treating or preventing renal and cardiovascular diseases.

Career Highlights

Throughout his career, Klemens Lustig has made significant advancements while working with renowned pharmaceutical organizations, including Bayer Pharma and Bayer Aktiengesellschaft. His work has played a crucial role in developing treatments that enhance patient care and quality of life.

Collaborations

Lustig has also collaborated with prominent professionals in the field, notably with colleagues such as Martina Delbeck and Carsten Schmeck. These collaborations have fostered an environment of innovation and creativity, allowing for the exchange of ideas and expertise in the pursuit of medical advancements.

Conclusion

Klemens Lustig continues to be a significant figure in the pharmaceutical industry, with his patents reflecting a dedication to improving health outcomes for patients suffering from serious respiratory and cardiovascular conditions. His innovative spirit and collaborative efforts position him as a valuable contributor to the ongoing evolution of medical treatments and therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…